Successful immune tolerance induction with factor VIII/von Willebrand factor concentrate in an elderly patient with severe haemophilia A and a high responder inhibitor.
作者信息
Rivolta Gianna Franca, Di Perna Caterina, Franchini Massimo, Riccardi Federica, Ippolito Luigi, Lombardi Maria, Tagliaferri Annarita
机构信息
Centro di Riferimento Regionale per la Cura dell'Emofilia e delle Malattie Emorragiche Congenite, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
出版信息
Blood Transfus. 2010 Jan;8(1):66-8. doi: 10.2450/2009.0078-09.
Abstract
摘要
相似文献
1
Successful immune tolerance induction with factor VIII/von Willebrand factor concentrate in an elderly patient with severe haemophilia A and a high responder inhibitor.在一名患有严重甲型血友病且抑制剂高反应性的老年患者中，使用凝血因子VIII/血管性血友病因子浓缩物成功诱导免疫耐受。
Blood Transfus. 2010 Jan;8(1):66-8. doi: 10.2450/2009.0078-09.
2
Adult haemophilia A patients with inhibitors: successful immune tolerance induction with a single FVIII/VWF product.成年血友病A抑制物患者：使用单一FVIII/VWF产品成功诱导免疫耐受。
Haemophilia. 2014 Nov;20(6):e414-7. doi: 10.1111/hae.12521. Epub 2014 Oct 21.
3
First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.在一项观察性免疫耐受诱导研究中，关于高危血友病A抑制物患者使用单一凝血因子VIII/血管性血友病因子浓缩物的免疫耐受的首份前瞻性报告。
Haemophilia. 2016 Jan;22(1):87-95. doi: 10.1111/hae.12774. Epub 2015 Jul 23.
4
Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH®) in 14 patients with severe haemophilia A.在14例重度甲型血友病患者中使用含血管性血友病因子的凝血因子VIII浓缩剂（Haemoctin SDH®）诱导免疫耐受。
Haemophilia. 2011 Sep;17(5):e837-40. doi: 10.1111/j.1365-2516.2011.02577.x. Epub 2011 Jun 7.
5
Immune tolerance induction with high von Willebrand factor/factor VIII content ratio concentrate in children with haemophilia A and high-responding inhibitor.使用血管性血友病因子/凝血因子VIII含量比高的浓缩物诱导甲型血友病和高反应性抑制物患儿的免疫耐受。
Haemophilia. 2009 Mar;15(2):617-9. doi: 10.1111/j.1365-2516.2008.01965.x. Epub 2009 Jan 20.
6
Inhibitors in haemophilia A: the role of VWF/FVIII concentrates--a meeting report.甲型血友病中的抑制剂：血管性血友病因子/凝血因子VIII浓缩物的作用——会议报告
Haemophilia. 2009 Mar;15(2):587-91. doi: 10.1111/j.1365-2516.2008.01944.x.
7
Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response.在高反应不良风险的血友病A抑制物患者中，使用高纯度血管性血友病因子/ VIII复合物浓缩物诱导免疫耐受。
Haemophilia. 2007 Jul;13(4):373-9. doi: 10.1111/j.1365-2516.2007.01484.x.
8
Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate.儿童和成人的初级和挽救性免疫耐受诱导：一项含有 VWF 的血浆源性 FVIII 浓缩物的多中心国际研究。
Haemophilia. 2014 Jan;20(1):83-91. doi: 10.1111/hae.12263. Epub 2013 Nov 19.
9
The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.使用凝血因子VIII/血管性血友病因子浓缩物诱导高滴度抑制物的甲型血友病患者产生免疫耐受：临床结局与抑制物表位谱的关联
Haemophilia. 2008 Mar;14(2):295-302. doi: 10.1111/j.1365-2516.2007.01620.x. Epub 2007 Dec 12.
10
Immune tolerance induction in patients with hemophilia A.血友病 A 患者的免疫耐受诱导。
Thromb Res. 2011 Jan;127 Suppl 1:S6-9. doi: 10.1016/j.thromres.2010.10.006. Epub 2010 Nov 5.
本文引用的文献
1
The role of VWF for the success of immune tolerance induction.血管性血友病因子（VWF）在诱导免疫耐受成功中的作用。
Thromb Res. 2008;122 Suppl 2:S7-S12. doi: 10.1016/S0049-3848(08)70003-3.
2
The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.使用凝血因子VIII/血管性血友病因子浓缩物诱导高滴度抑制物的甲型血友病患者产生免疫耐受：临床结局与抑制物表位谱的关联
Haemophilia. 2008 Mar;14(2):295-302. doi: 10.1111/j.1365-2516.2007.01620.x. Epub 2007 Dec 12.
3
Inhibitors in haemophilia A: current management and open issues.甲型血友病的抑制剂：当前的管理及未解决的问题
Haemophilia. 2007 Dec;13 Suppl 5:52-60. doi: 10.1111/j.1365-2516.2007.01574.x.
4
Inhibitor development in haemophilia A: the role of von Willebrand factor/factor VIII concentrates.甲型血友病的抑制剂研发：血管性血友病因子/凝血因子 VIII 浓缩物的作用
Haemophilia. 2007 Dec;13 Suppl 5:47-51. doi: 10.1111/j.1365-2516.2007.01571.x.
5
Immune tolerance therapy utilizing factor VIII/von Willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors.在高滴度因子VIII抑制剂的甲型血友病患者中利用因子VIII/血管性血友病因子浓缩物进行免疫耐受治疗。
Haemophilia. 2008 Jan;14(1):50-5. doi: 10.1111/j.1365-2516.2007.01560.x. Epub 2007 Oct 18.
6
Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response.在高反应不良风险的血友病A抑制物患者中，使用高纯度血管性血友病因子/ VIII复合物浓缩物诱导免疫耐受。
Haemophilia. 2007 Jul;13(4):373-9. doi: 10.1111/j.1365-2516.2007.01484.x.
7
International workshop on immune tolerance induction: consensus recommendations.免疫耐受诱导国际研讨会：共识性建议
Haemophilia. 2007 Jul;13 Suppl 1:1-22. doi: 10.1111/j.1365-2516.2007.01497.x.
8
9
Role of von Willebrand factor in immune tolerance induction.血管性血友病因子在免疫耐受诱导中的作用。
Blood Coagul Fibrinolysis. 2005 Apr;16 Suppl 1:S27-31. doi: 10.1097/01.mbc.0000167660.30886.e9.
10
The epidemiology of inhibitors in haemophilia A: a systematic review.甲型血友病中抑制物的流行病学：一项系统评价。
Haemophilia. 2003 Jul;9(4):418-35. doi: 10.1046/j.1365-2516.2003.00780.x.
Zotero 插件